Announcement of the 17th NCGM International Infectious Diseases Forum
The 17th NCGM International Forum on Infectious Diseases will focus on viral hepatitis, with emphasis on hepatitis B virus (HBV) infection as a significant infectious disease. The World Health Organization estimates that the number of new HBV infections worldwide reaches approximately 1.5 million cases per year, with the number of people living with chronic hepatitis B totaling approximately 300 million. Under the theme "Forefront of Diagnosis & Treatment of Viral Hepatitis, and Future Prospects," domestic and international experts will present their latest findings. The forum will primarily address trends in HBV infection and treatment in Asian countries, as well as diagnostic markers developed in Japan and the current state and future outlook of hepatitis treatment.- ・Date and time: Thursday, September 5, 2024. 15:00-17:30, Japan Standard Time (JST)
The 17th NCGM International Infectious Diseases Forum was successfully closed. The presentation slides approved for publication on this page are now available. Please click on the lecture title to access the related slides. - ・Event format: Online Symposium Simultaneous interpretation (English-Japanese)
- ・Participation fee: Free of charge
- ・Registration: Pre-registration required. Please register at HERE
- ・Registration Deadline: Monday, September 2, 2024
Program
1. Report: The ARO Alliance for Southeast and East Asia (ARISE): Where We Stand and Where to Go
Dr. Muchanga Sifa Marie Joelle
(Senior Research Fellow, Department of International Trials, Center for Clinical Sciences, NCGM, Japan)
2. Symposium: “Forefront of Diagnosis & Treatment of Viral Hepatitis, and Future Prospects”
Co-chairs: Dr. Wataru Sugiura (Director, Center for Clinical Sciences, NCGM, Japan)
Dr. Tatsuya Kanto (Director, The Research Center for Hepatitis and Immunology, Research Institute, NCGM, Japan)
Lecture 1: Clinical Efficacy of a Novel, High-Sensitivity HBcrAg Assay in the Management of Chronic Hepatitis B
Dr. Takako Inoue
(Associate Professor, Graduate School of Medical Sciences, Nagoya City University, Japan)
Lecture 2: Development of New Biomarkers for Hepatitis B
Dr. Masaya Sugiyama
(Director, Department of Viral Pathogenesis and Controls, Research Institute, NCGM, Japan)
Lecture 3: Epidemiology, Natural History, and Control of Chronic Hepatitis B Virus
Dr. Mei-Hsuan Lee
(Professor, Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taiwan)
Lecture 4: Chronic Hepatitis B in Thailand: Epidemiology, Treatment, and Current Challenges
Dr. Pisit Tangkijvanich
(Professor, Head of Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Thailand)
Lecture 5: Drug Discovery Research to Clinical Application for Chronic Hepatitis B
Dr. Yasuhito Tanaka
(Professor, Department of Gastroenterology and Hepatology, Kumamoto University, Japan)
Panel discussion
*This forum is organized and overseen by NCGM as part of AMED's “Clinical Research and Trial Network Construction Project in Asia.”
Flyer download
Contact
Secretariat of NCGM International Infectious Diseases ForumDepartment of International Trials, Center for Clinical Sciences,
National Center for Global Health and Medicine
1-21-2 Toyama Shinjuku-ku Tokyo, 162-8655 Japan
Email：ncgm-iidf@event-info.jp
About the International Infectious Disease Forum
Overview of the Forum
International Infectious Disease Forum promotes international development through public-private-academia collaboration, mainly in the field of infectious diseases. Experts provide the latest information and exchange opinions among relevant parties such as companies, medical and research institutions. We support the development of pharmaceuticals and medical devices for prevention, diagnosis, treatment as well as clinical research utilizing the international collaborative clinical research platform established by NCGM and the international clinical trial network, ARO Alliance for Southeast & East Asia (ARISE).
Content of the Forum
- ・Latest trends in infectious diseases in Japan and overseas
- ・Latest findings and countermeasures for infectious diseases such as AMR
- ・Academic information on new medical technologies and pharmaceuticals
- ・Domestic medical administration and overseas regulations
- ・Case reports on overseas clinical research and trial
- ・Introduction of NCGM's international projects and research, etc.
Past Forums
- Sep 29, 2023
16th IIDF Updates on AMR - Trends and Countermeasures for Antimicrobial-resistant Bacterial Infections, and New Antibiotics - Jan 17, 2023
15th IIDF Infectious Diseases Updates - Prevention to Treatment - Jun 17, 2022
14th IIDF From Japan to overseas - International Activities of Japanese Academia and Pharmaceuticals and Medical Devices - Dec 13, 2021
13th IIDF Pharmaceutical R&D through International Cooperation in the field of SARS CoV-2 Infectious Diseases - Jun 07, 2021
12th IIDF Japanese Technology in SARS CoV-2 Infection - Jan 29, 2021
11th IIDF Past, Present and Future of the R and D in Infectious Diseases Arena - Nov 3, 2020
10th IIDF Go Global - For a Global Clinical Study Platform Bridging Japan and Asia for COVID-19 - - Mar 10, 2020→Cancelled
9th IIDF - Dec 13, 2019
8th IIDF Global Health Issue: Vaccines for Preventable Diseases - Oct 8, 2019
7th IIDF Global Health Issue: AMR Control - Jun 7, 2019
6th IIDF Access to Unmet Needs, Information and Regulatory - Mar 11, 2019
5th IIDF - Dec 21, 2018
4th IIDF Expansion of Clinical Trials in Asian Region - Oct 4, 2018
3rd IIDF Recent Trends of Infectious Diseases in the Asian Region - Jul 20, 2018
2nd IIDF Overview of Global Clinical Research Network Bases Project - Mar 7, 2018
1st IIDF
